Medical News

RSS

Bio-Path Holdings to develop liposome tumor targeting technology

Bio-Path Holdings, Inc. (OTCBB: BPTH), a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today the Company has executed an exclusive license with The University of Texas M. D. Anderson Cancer Center to develop liposome tumor targeting technology. Bio-Path is currently developing a neutral-lipid based liposome delivery technology for nucleic acid cancer drugs (including antisense and siRNA molecules).

23 Sep 2009

$Using moldable pastes to repair fractures in the future$

Using moldable pastes to repair fractures in the future

New stem cell studies at the University of Maryland Dental School demonstrate that surgeons could one day routinely use strong, moldable, and injectable pastes to regenerate needed bone tissue to repair broken bones, fractures, genetic defects, even combat bone wounds.

23 Sep 2009

New method to diagnose active tuberculosis

Active tuberculosis can be rapidly identified in patients with negative sputum tests by a new method, according to European researchers. Active tuberculosis (TB) is the seventh-leading cause of death worldwide, and while the diagnosis of active TB can be rapidly established when the bacteria can be identified on sputum microscopy, in about half of all cases, the TB bacterium cannot be detected, making another diagnostic option critical in efforts to control the spread of TB.

23 Sep 2009

Community Hospital South implements GE Healthcare's Centricity Enterprise solution

GE Healthcare, a leading provider of healthcare information technology, announced Community Hospital South (Indianapolis) is now live with GE Centricity™ Enterprise 6.1 and Monitored Care, an integrated clinical, financial and administrative solution that helps streamline workflow and improve productivity across the continuum of care.

23 Sep 2009

Medical students post unprofessional content online

A majority of medical schools surveyed report they have experienced incidents of students posting unprofessional content online, including incidents involving violation of patient confidentiality, with few schools having policies to address these types of postings, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.

23 Sep 2009

Hyperthermia with chemotherapy prolongs survival

BSD Medical Corporation (NASDAQ:BSDM) reports that significant and “medical practice changing” clinical study results were the subject of a news briefing at Europe’s largest cancer congress, ECCO15 – ESMO34, which is being held September 20 to 24, 2009, in Berlin, Germany.

23 Sep 2009

Researching the causes of Alzheimer's disease

The standard explanation for what causes Alzheimer's is known as the amyloid hypothesis, which posits that the disease results from of an accumulation of the peptide amyloid beta, the toxic protein fragments that deposit in the brain and become the sticky plaques that have defined Alzheimer's for more than 100 years.

23 Sep 2009

Sterile cord blood collection bag now from PacifiCord

Dedicated to serving the private cord blood banking needs of Southern California, PacifiCord (www.pacificord.com) today announced it has secured Pall Corporation’s sterile cord blood collection bag. Since April 2006, this industry-best sterile bag has been unavailable for purchase due to prior limiting agreements with its manufacturer; no longer.

23 Sep 2009

Former senior manager sentenced for defrauding Hitachi America Group Health and Welfare Plan

Preet Bharara, the U.S. Attorney for the Southern District of New York, announced that Dennis M. Dowd, formerly the senior manager of human resources of Hitachi America Ltd. (Hitachi America), was sentenced today in Manhattan federal court to 57 months in prison for defrauding the Hitachi America Group Health and Welfare Plan (the Plan) of more than $6 million.

23 Sep 2009

Report on species-crossing microbes and H1N1

Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.

23 Sep 2009

NIH grants $3.4M to develop tools for identification of prostate cancer using MRI

Rutgers University and two collaborators have received a $3.4 million research grant to develop tools aimed at improving the identification of prostate cancer using MRI, or magnetic resonance imaging.

23 Sep 2009

Family dinners can make a difference in children's lives

Compared to teens who have frequent family dinners (five or more per week), those who have infrequent family dinners (fewer than three per week) are twice as likely to use tobacco or marijuana; more than one and a half times likelier to use alcohol; and twice as likely to expect to try drugs in the future, according to The Importance of Family Dinners V, a new report by The National Center on Addiction and Substance Abuse (CASA) at Columbia University.

23 Sep 2009

ACR Image Metrix successfully completes two years, looks forward to increased business in third year

ACR Image Metrix™, an imaging contract research organization (CRO), exceeded its goals by initiating projects for over 30 pharmaceutical, biotechnology and medical device companies through its second full year of operation.

23 Sep 2009

Medtronic's transcatheter valves to be presented at TCT 2009

With the promise of percutaneous treatments for patients with diseased heart valves growing, Medtronic, Inc., announced today that more presentations than ever before – at least 25 – on the company’s portfolio of unique transcatheter valves will be presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009, the world’s premier annual meeting for interventional cardiologists.

23 Sep 2009

Results of OASIS clinical trial reported by Cardiovascular Systems

Two-year follow-up of patients in the first-ever prospective, multi-center clinical trial evaluating a plaque removal product show promising results after treatment with the Diamondback 360® PAD System, a minimally invasive catheter system that removes hardened plaque to restore blood flow in arteries.

23 Sep 2009

Noveko to provide antimicrobial face masks and respirators to Air Transat

Noveko International Inc. ("the Company") announces that its subsidiary Noveko Inc. ("Noveko") has won a first order from Air Transat, Canada's leading holiday travel airline, for some 500,000 Noveko(TM) antimicrobial face masks and respirators as well as for AZURO(TM) hand sanitizers.

23 Sep 2009

Civil action against BioAlliance Pharma gets rejected

BioAlliance Pharma SA (Paris:BIO) announces today that the American District Judge has granted the motion to dismiss of BioAlliance Pharma and one of its executive in response to the civil action filed by Eurofins. Eurofins filed an appeal.

23 Sep 2009

Declining performance of muscles linked to harmful byproducts of air we breathe

If you think the air outside is polluted, a new research report in the September 2009 issue of the journal Genetics (http://www.genetics.org) might make you to think twice about the air inside our bodies too. That's because researchers show how about 3 percent of the air we breathe gets converted into harmful superoxides, which ultimately harm our muscles.

23 Sep 2009

NIH, NephCure Foundation and University of Michigan support study of nephrotic syndrome

University of Michigan Health System researchers will lead a $10.25 million effort to study rare kidney diseases that cause kidney failure and the need for dialysis.

23 Sep 2009

Biotime's new subsidiary to focus on clinical development and marketing therapeutic stem cell products in China

BioTime, Inc. (OTCBB:BTIM) announced today that it will organize a new subsidiary, BioTime Asia, Limited, for the purpose of clinically developing and marketing therapeutic stem cell products in the People’s Republic of China, and marketing stem cell research products in China and other countries in Asia.

23 Sep 2009